In early May, Ranbaxy faced criminal charges brought against it by the Indian state of Kerala due to subpotent amoxycillin and the labeling of an osteoporosis drug as a dietary supplement.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
